Cargando…
Alzheimer’s Amyloidopathy: An Alternative Aspect
The ‘amyloid hypothesis’ dominates Alzheimer’s disease (AD) research but has failed to deliver effective therapies. Amyloid precursor protein (APP) and presenilin-1 (PSEN1) genetic mutations are undoubtedly pathogenic, albeit by unclear mechanisms. Conversely, high dose B-vitamins convincingly slow...
Autores principales: | Regland, Björn, McCaddon, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484249/ https://www.ncbi.nlm.nih.gov/pubmed/30814347 http://dx.doi.org/10.3233/JAD-181007 |
Ejemplares similares
-
COVID-19: A methyl-group assault?
por: McCaddon, Andrew, et al.
Publicado: (2021) -
Homocysteine and cognitive impairment; a case series in a General Practice setting
por: McCaddon, Andrew
Publicado: (2006) -
Oxidative stress: culprit or consequence in Alzheimer’s amyloidopathy
por: Sharma, Chanchal, et al.
Publicado: (2023) -
Examining the Diagnosis and Treatment Experiences of People Living With Autoimmune Gastritis and Pernicious Anemia
por: Cotton, Martine, et al.
Publicado: (2023) -
Homocysteine—a retrospective and prospective appraisal
por: McCaddon, Andrew, et al.
Publicado: (2023)